Sign up


Match Document Document Title
US20130253142 SEPARATING AGENT FOR PROTEIN PURIFICATION AND PROTEIN PURIFICATION METHOD  
A novel separating agent for protein purification which not only can adsorb proteins in a sufficient amount for protein purification from a low concentration buffer but also can desorb the adsorbed...
US20130023697 METHOD FOR PRODUCING OXIME  
This invention relates to a process for producing an oxime comprising reacting a ketone and hydroxylamine in the presence of a carboxylic acid and/or its salt in a system consisting of an aqueous...
US20140081045 METAL PLATING COMPOSITIONS AND METHODS  
Disclosed are metal plating compositions and methods. The metal plating compositions provide good leveling performance and throwing power.
US20110318479 METAL PLATING COMPOSITIONS AND METHODS  
Disclosed are metal plating compositions and methods. The metal plating compositions provide good leveling performance and throwing power.
US20110039866 SELECTIVE SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS  
Described herein are compounds useful as antagonists of sphingosine-1-phosphate receptors. Further described herein is the use of these compounds and related pharmaceutical compositions to treat...
US20110218312 METHOD FOR PRODUCING N-ISOPROPYL(METH)ACRYLAMIDE  
A novel process is described which allows N-isopropyl(meth)acrylamide to be obtained in high purity and yield in a simple manner, by reacting methacrylic anhydride with isopropylamine, optionally...
US20120034464 DIAMOND PARTICLES HAVING ORGANIC COMPOUNDS ATTACHED THERETO, COMPOSITIONS THEREOF, AND RELATED METHODS  
A substance includes diamond particles having a maximum linear dimension of less than about 1 μm and an organic compound attached to surfaces of the diamond particles. The organic compound may ...
US20110257386 ISOLATION OF NUCLEIC ACID  
A method for isolating a nucleic acid comprises: binding the nucleic acid to a solid phase at a first pH in the presence of a binding buffer, washing the bound nucleic acid with a wash solution,...
US20100047360 Use Of Polyamines In The Treatment Of Psoriasis  
The present invention provides unbranched aliphatic polyamines for use in therapy, particularly for use in the treatment of psoriasis and compositions containing polyamines.
US20120244627 Methods for Quantifying Vitamin D Metabolites by Mass Spectrometry  
Provided are methods of detecting the presence or amount of a dihydroxyvitamin D metabolite in a sample using mass spectrometry. The methods generally comprise associating an amine with a...
US20120302794 Derivatives of venlafaxine and methods of preparing and using the same  
Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited...
US20130165527 Method for Administering an NMDA Receptor Antagonist to a Subject  
Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is...
US20120178747 Compositions and methods for bone formation and remodeling  
The mechanism by which the high bone mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates the canonical Wnt signaling was investigated. The mutation was previously shown to reduce Dkk...
US20100298308 Compositions and methods for bone formation and remodeling  
The mechanism by which the high bone mass (HBM) mutation (G171V) of the Wnt coreceptor LRP5 regulates the canonical Wnt signaling was investigated. The mutation was previously shown to reduce Dkk...
US20100324064 NOVEL ANALOGS OF CHOLINE FOR NEUROPROTECTION AND COGNITIVE ENHANCEMENT IN NEURODEGENERATIVE DISORDERS  
The present invention relates to novel analogs of choline and methods of use or treatment of neurodegenerative disorders and/or conditions such as Parkinson's disease, Huntington disease,...
US20110046138 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS  
A series of novel compounds showing anticonvulsant activity is described. Such pharmaceutically active compounds may also show utility in the treatment of other central nervous system (“CNS”) dis...
US20110290418 HYDROGEN PEROXIDE COMPLEXES AND THEIR USE IN THE CURE SYSTEM OF ANAEROBIC ADHESIVES  
Provided is a complex of hydrogen peroxide and at least one compound represented by Formula I: wherein X is: —C(R3)3, —C≡C(R3), —O(R3), —N(R3)2, or —S(R3); and R1, R2, and R3 are each independent...
US20140087005 MODULATORS OF HSP70/DNAK FUNCTION AND METHODS OF USE THEREOF  
Compositions and methods for modulating HSP70 function, particularly for the targeted killing of cancer cells, are disclosed.
US20110189125 Modulators of HSP70/DnaK Function and Methods of Use Thereof  
Compositions and methods for modulating HSP70 function, particularly for the targeted killing of cancer cells, are disclosed.
US20110021827 CRYSTALLIZATION OF IODIXANOL USING ULTRASOUND  
This invention relates to the manufacture of iodixanol (1,3-bis(acetamido)-N,N′-bis[3,5-bis (2,3-dihydroxypropylaminocarbonyl)-2,4,6-triiodophenyl]-2-hy droxypropane), more specifically to the p...
US20130217778 METHODS AND COMPOSITIONS FOR THE IMPROVEMENT OF SKELETAL MUSCLE FUNCTION IN A MAMMAL  
The present invention is directed to the treatment of muscular dysfunction or increasing muscle strength and/or decreasing muscle fatigue in a subject using a composition that includes a biguanide...
US20100051879 Functionalized Boron Nitride Nanotubes  
A plasma treatment has been used to modify the surface of BNNTs. In one example, the surface of the BNNT has been modified using ammonia plasma to include amine functional groups. Amine...
US20130231326 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...
US20130196966 SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...
US20110172202 SELECTIVE SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS AND METHODS OF CHIRAL SYNTHESIS  
Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds...
US20090137847 Decomposing system for polyisocyanate residues, and start-up method for the same  
An object of the invention is to provide a decomposing system for polyisocyanate residues that is capable of suppressing reaction of polyisocyanate residues with high temperature and high pressure...
US20130079560 SOLID BASE CATALYST AND METHOD FOR MAKING AND USING THE SAME  
A solid base catalyst having a carrier, an organic base, and an inorganic base. Both of the organic base and inorganic base are loaded on the carrier. The solid base catalyst is especially suitable...
US20140107215 CLENBUTEROL FOR USE IN TREATMENT OF AUTISM  
Clenbuterol or its salt for use in the treatment of autism, in particular pediatric autism. Improved contact with surroundings, better concentration, improved ability to plan a specific task,...
US20130217920 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS  
This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteraryl vinyl)-phenyl methyl amine derivatives.
US20130172620 METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS  
This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteroaryl vinyl)-phenyl methyl amine derivatives.
US20120077211 STABLE COMPOSITIONS COMPRISING CHROMOGENIC COMPOUNDS AND METHODS OF USE  
Compositions, assays, methods, and kits are disclosed for use in applications that utilize oxidation of a chromogenic electron donor such as diaminobenzidine (DAB) to generate a signal....
US20110002985 ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING  
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier...
US20130078879 REACTIVE MONOMER FOR A COATING AND/OR REACTIVE COATING  
Disclosed herein are coating solutions comprising a reactive monomer, process and compositions for preparing the same that are suitable for a coating and/or reactive coating. More particularly, the...
US20130090471 METHOD FOR DETECTING COMPOUNDS THAT MODULATE THE CHOLESTEROL METABOLISM  
The present invention relates to a method for identifying compounds that modulate cholesterol metabolism by detecting enzyme activities involved in the synthesis or catabolism of cholesterol. Said...
US20120065247 MODULATING IRES-MEDIATED TRANSLATION  
Provided herein are compounds and methods for use in preventing or treating a viral infection mediated by a virus comprising an IRES-containing RNA molecule or cancer related to an increase or...
US20080176945 Carboxilic Acid Amides Provoking A Cooling Sensation  
The present invention refers to cooling compounds of formula I wherein R1, R2, R3, X, Y, Z, and m have the same meaning as given in the specification. The present invention refers furthermore to a...
US20110190540 Methods for Preparing S1P Receptor Agonists and Antagonists  
Disclosed herein are methods of making compounds which are agonists or antagonists of one or more of the individual receptors of the S1P receptor family.
US20100052526 PYRENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME  
A pyrene compound is provided. The pyrene compound is represented by Formula 1: wherein A1 and A2 are as defined in the specification. Further provided is an organic electroluminescent device using...
US20120022086 CATECHOLAMINE DERIVATIVES FOR OBESITY AND NEUROLOGICAL DISORDERS  
Novel compounds, compositions, and methods related to the activation of the TrkB receptor are provided. The methods include administering in vivo or in vitro a therapeutically effective amount of a...
US20110306792 PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF  
The present invention relates to a process for preparing tolterodine and the L-tartrate thereof. The preparation consists of the following steps: A) ammonolysis reaction between diisopropylamine...
US20120277468 TITANIUM-SILICALITE MOLECULAR SIEVE, METHOD FOR PREPARING THE SAME AND METHOD FOR PREPARING CYCLOHEXANONE OXIME USING THE MOLECULAR SIEVE  
The present invention provides a titanium-silicalite molecular sieve and a method for preparing the same. The method includes the steps of preparing a mixture of a titanium source, a silicon...
US20120058992 THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF ANGIOGENESIS  
The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that...
US20120264978 COMPOSITION FOR ADMINISTERING AN NMDA RECEPTOR ANTAGONIST TO A SUBJECT  
The invention provides compostions for administering memantine to a subject. Memantine in an extended release form containing 22.5 to 30 mg memantine or a pharmaceutically acceptable salt achieves...
US20140106415 METHOD FOR PRODUCING ACRYLAMIDE AQUEOUS SOLUTION  
There is provided a method for producing an aqueous acrylamide solution by producing acrylamide by reacting a composition including acrylonitrile with water, in which the composition including...
US20130006016 BETA-HYDROXYALKYLAMIDES, METHOD FOR THEIR PRODUCTION AND USE THEREOF  
The invention relates to novel β-hydroxyalkylamides, to a method for their production and to the use thereof.
US20130231332 SMALL MOLECULE INHIBITORS OF EBOLA AND LASSA FEVER VIRUSES AND METHODS OF USE  
The present invention relates to compositions and methods for the treatment of infection by enveloped viruses, such as Ebola and Lassa fever viruses.
US20110313189 1.4-FULLERENE ADDENDS IN PHOTOVOLTAIC CELLS  
1,4 fullerene deriatives useful for solar cells are provided, where their structures allow for straightforward functionalizations to tune their properties in terms of solubility and LUMO energy...
US20110215715 CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS  
This invention relates to chrysene compounds that are useful in electroluminescent applications and are capable of blue or green emission. It also relates to electronic devices in which the active...
US20130253212 PASSIVE METHODS FOR ANTI-MICROBIAL BIOLOGICAL MESHES  
Tissue matrices having anti-microbial properties are provided. In certain embodiments, the tissue matrices include cationic anti-microbial agents that form a stable bond with the tissue matrices...
US20100331577 Method for radio-labeling serotonin transporter ligand, 123I-IADM  
There is disclosed a method for using 123I to radiolabel SnADAM become an serotonin transporter radiotracer(123I -ADAM). At first, there is provided SnADAM solution via mixing SnADAM with ethanol....